Detectable size of melanoma metastases to brain on PET/CT

被引:2
作者
Oldan, Jorge D. [1 ]
Glaubiger, Samuel A. [1 ]
Khandani, Amir H. [1 ]
Jewells, Valerie L. [1 ]
机构
[1] Chapel Hill Hosp, UNC Dept Radiol, 101 Manning Dr, Chapel Hill, NC 27514 USA
关键词
Melanoma; PET; CT; Brain metastases; HEAD;
D O I
10.1007/s12149-020-01481-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We aimed to determine at what size melanoma metastases become detectable by PET/CT. Methods We reviewed a total of 293 whole-body PET/CT studies performed on 212 patients for staging of melanoma where there was an MRI within a month of the PET/CT. MR and PET/CT were reviewed independently by separate readers. Results PET/CT revealed an overall incidental true-positive rate of 1% on a per-patient basis, consistent with other studies, with 'hot' lesions (more avid than brain parenchyma) visible at smaller sizes than 'cold' lesions. Conclusions PET/CT can detect metastatic melanoma lesions over about 2 cm in size, with hot lesions generally visible at smaller sizes.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 50 条
  • [1] Detectable size of melanoma metastases to brain on PET/CT
    Jorge D. Oldan
    Samuel A. Glaubiger
    Amir H. Khandani
    Valerie L. Jewells
    Annals of Nuclear Medicine, 2020, 34 : 545 - 548
  • [2] Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
    Fonti, Rosa
    Pellegrino, Sara
    Mainolfi, Ciro Gabriele
    Matano, Elide
    Del Vecchio, Silvana
    DIAGNOSTICS, 2020, 10 (06)
  • [3] Anal Malignant Melanoma Manifesting Hepatic Metastases Shown on FDG PET/CT
    Zou, Sijuan
    Cheng, Zhaoting
    Song, Shuang
    Kuang, Dong
    Zhu, Xiaohua
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (05) : 386 - 388
  • [4] Melanoma brain metastases: the impact of nodal disease
    Jackson, James E.
    Burmeister, Bryan H.
    Burmeister, Elizabeth A.
    Foote, Matthew C.
    Thomas, Janine M.
    Meakin, Janelle A.
    Smithers, B. Mark
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (01) : 81 - 85
  • [5] Primary Anorectal Melanoma on FDG PET/CT
    Li, Zu-Gui
    Qin, Xiao-Jing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) : 762 - 764
  • [6] Management of brain metastases in melanoma
    Rutkowski, Piotr
    Kiprian, Dorota
    Dudzisz-Sledz, Monika
    Switaj, Tomasz
    Michalik, Radoslaw
    Spalek, Mateusz
    Kozak, Katarzyna
    Mandat, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (01): : 51 - 61
  • [7] Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases
    Ho, Kung-Chu
    Toh, Cheng-Hong
    Li, Shih-Hong
    Liu, Chien-Ying
    Yang, Cheng-Ta
    Lu, Yu-Jen
    Su, Tzu-Pei
    Wang, Chih-Wei
    Yen, Tzu-Chen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (02) : 467 - 477
  • [8] Targeted Therapies for Melanoma Brain Metastases
    Anna S. Berghoff
    Matthias Preusser
    Current Treatment Options in Neurology, 2017, 19
  • [9] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [10] Management of brain metastases, in patients with melanoma
    Tarhini, AA
    Agarwala, SS
    CURRENT OPINION IN ONCOLOGY, 2004, 16 (02) : 161 - 166